Bellicum Pharmaceuticals, Inc.
News
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Benzinga Gainers Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in the company.\n more…
Short Volatility Alert: Bellicum Pharma
Benzinga On Monday, shares of Bellicum Pharma BLCM experienced volatile short activity. After the activity, the stock price went up +102.85% to $0.57. The overall sentiment for BLCM has been Bearish. The signal from the volatility alert is trending Bearish. Therefore, the recommendation is to Strong Sell.\n more…
Is Bellicum Pharmaceuticals (BLCM) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research Here is how Bellicum Pharmaceuticals (BLCM) and Chemed (CHE) have performed compared to their sector so far this year.\n\n The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Bellicum Pharmaceuticals (BLCM) been one...\n more…
Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternatives
Globe Newswire HOUSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), today announced its decision to discontinue its ongoing Phase 1/2 clinical trials evaluating the safety and preliminary efficacy of its GoCAR-T cell product candidates in combination with rimiducid in heavily ...\n more…
Is Bellicum Pharmaceuticals (BLCM) Outperforming Other Medical Stocks This Year?
Zacks Investment Research Here is how Bellicum Pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared to their sector so far this year.\n\n The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bellicum ...\n more…